The Ubiquitin Ligase TRIM56 Regulates Innate Immune Responses to Intracellular Double-Stranded DNA

The innate immune system detects pathogen- and host-derived double-stranded DNA exposed to the cytosol and induces type I interferon (IFN) and other cytokines. Here, we identified interferon-inducible tripartite-motif (TRIM) 56 as a regulator of double-stranded DNA-mediated type I interferon inducti...

Full description

Saved in:
Bibliographic Details
Published inImmunity (Cambridge, Mass.) Vol. 33; no. 5; pp. 765 - 776
Main Authors Tsuchida, Tetsuo, Zou, Jian, Saitoh, Tatsuya, Kumar, Himanshu, Abe, Takayuki, Matsuura, Yoshiharu, Kawai, Taro, Akira, Shizuo
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 24.11.2010
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The innate immune system detects pathogen- and host-derived double-stranded DNA exposed to the cytosol and induces type I interferon (IFN) and other cytokines. Here, we identified interferon-inducible tripartite-motif (TRIM) 56 as a regulator of double-stranded DNA-mediated type I interferon induction. TRIM56 overexpression enhanced IFN-β promoter activation after double-stranded DNA stimulation whereas TRIM56 knockdown abrogated it. TRIM56 interacted with STING and targeted it for lysine 63-linked ubiquitination. This modification induced STING dimerization, which was a prerequisite for recruitment of the antiviral kinase TBK1 and subsequent induction of IFN-β. Taken together, these results indicate that TRIM56 is an interferon-inducible E3 ubiquitin ligase that modulates STING to confer double-stranded DNA-mediated innate immune responses. ► TRIM56 expression is induced by dsDNA and poly (I:C) stimulation ► TRIM56 enhanced IFN-β promoter activation after dsDNA stimulation ► TRIM56 promoted K63-linked ubiquitination and dimerization of STING ► These modifications are required to form a complex with TBK1 and induce IFN-β
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:1074-7613
1097-4180
1097-4180
DOI:10.1016/j.immuni.2010.10.013